Header graphic for print
LimeGreenIP News

Tag Archives: biotech

Privacy and Cybersecurity KnowledgeShare event: Sept 19, London

Join us on Thursday 19 September for our Privacy and Cybersecurity KnowledgeShare in London. We’ll share our latest thinking on the key privacy and cybersecurity issues faced by those with data protection responsibilities within organisations. Our all-day event will cover a lot of ground through incisive quick-fire presentations, Q&A panels and hands-on workshops. Topics will include:

IPMT practice welcomes four new lateral partners

We are delighted to welcome four new lateral partners to our San Francisco and Boston offices – Krista Schwartz, Patrick Michael, Kristin Connarn, and Bob Underwood (officially joining later this month). Our newest additions bring our U.S. lateral hires to six in the span of six months, following the additions of Simon Roberts and Jason

Brexit Bill – Impact on patents

The UK government’s draft EU Withdrawal Bill (the “Brexit Bill“) aims to incorporate EU directives and regulations into UK domestic law in their current form immediately following Brexit (“Retained EU Law“).  This article considers the impact the Brexit Bill will have on some key patent issues. The Brexit Bill and EU Decisions In addition to

IP is at the heart of life sciences innovation

In recent years, technology and innovation has advanced at an unprecedented pace. Flying taxi drones, self-driving cars and 3D-printers immediately come to mind. However, exciting progress has been made in life sciences and the healthcare sector as well. With CRISPR, bionic limbs and 3D-printed tissue, the medical sector has never been closer to eliminating disease